Full Text View
Tabular View
No Study Results Posted
Related Studies
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
This study is currently recruiting participants.
Study NCT00094029   Information provided by Pfizer
First Received: October 8, 2004   Last Updated: November 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastrointestinal Neoplasm
Additional conditions recognized in this trial
Digestive System Neoplasms
Gastrointestinal Neoplasms
Gastrointestinal Stromal Tumors
Neoplasms
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Neoplasms by Site
Interventions listed in this trial
SU011248
Additional drug interventions recognized in this trial
Sunitinib
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services